Mangoceuticals/$MGRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Mangoceuticals
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
Ticker
$MGRX
Sector
Primary listing
Employees
3
Headquarters
Website
Mangoceuticals Metrics
BasicAdvanced
$25M
-
-$3.14
2.43
-
Price and volume
Market cap
$25M
Beta
2.43
52-week high
$5.33
52-week low
$1.32
Average daily volume
157K
Financial strength
Current ratio
0.074
Quick ratio
0.063
Total debt to equity
3.275
Profitability
EBITDA (TTM)
-10.539
Gross margin (TTM)
61.00%
Net profit margin (TTM)
-2,752.32%
Operating margin (TTM)
-2,419.22%
Revenue per employee (TTM)
$170,000
Management effectiveness
Return on assets (TTM)
-43.25%
Return on equity (TTM)
-85.90%
Valuation
Price to revenue (TTM)
20.376
Price to book
1.21
Price to tangible book (TTM)
-16.06
Price to free cash flow (TTM)
-1.805
Free cash flow yield (TTM)
-55.41%
Free cash flow per share (TTM)
-1.214
Growth
Revenue change (TTM)
-40.47%
Earnings per share change (TTM)
-51.48%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Mangoceuticals stock?
Mangoceuticals (MGRX) has a market cap of $25M as of September 11, 2025.
What is the P/E ratio for Mangoceuticals stock?
The price to earnings (P/E) ratio for Mangoceuticals (MGRX) stock is 0 as of September 11, 2025.
Does Mangoceuticals stock pay dividends?
No, Mangoceuticals (MGRX) stock does not pay dividends to its shareholders as of September 11, 2025.
When is the next Mangoceuticals dividend payment date?
Mangoceuticals (MGRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Mangoceuticals?
Mangoceuticals (MGRX) has a beta rating of 2.43. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.